F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

Health
By Reed Abelson and Rebecca Robbins from NYT Health https://ift.tt/Ll4nHVQ
via IFTTT Prices (Fares, Fees and Rates), Drugs (Pharmaceuticals), Health Insurance and Managed Care, Suits and Litigation (Civil), Presidential Election of 2024, Drugstores, Insulin, Regulation and Deregulation of Industry The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda